Matches in SemOpenAlex for { <https://semopenalex.org/work/W171497108> ?p ?o ?g. }
Showing items 1 to 55 of
55
with 100 items per page.
- W171497108 endingPage "55" @default.
- W171497108 startingPage "51" @default.
- W171497108 abstract "Antibodies to IgE are a totally new class of medications currently used to enhance the supervision over severe persistent atopic bronchial asthma. Omalizumab is the most well studied, first and only medication of this group, which is recommended for the application and is allowed for treatment of uncontrolled bronchial asthma among adults and children aged 12 and over in different countries of the world, including Russia. High omalizumab assisted treatment costs, as well as the need in the monthly visits to the doctor for the omalizumab injections are justified for the patients, requiring repeat hospitalizations, emergency medical aid, using high doses of the inhalation and/or systemic glucocorticosteroids. The article reviews the criteria for the selection of patients fit for omalizumab assisted treatment. Key words: omalizumab, anti-ige-antibodies, bronchial asthma, allergic rhinitis, treatment, children." @default.
- W171497108 created "2016-06-24" @default.
- W171497108 creator A5013409247 @default.
- W171497108 date "2007-01-01" @default.
- W171497108 modified "2023-09-25" @default.
- W171497108 title "ОМАЛИЗУМАБ У ДЕТЕЙ С БРОНХИАЛЬНОЙ АСТМОЙ: ПОКАЗАНИЯ К ПРИМЕНЕНИЮ" @default.
- W171497108 cites W1828975699 @default.
- W171497108 cites W1995784152 @default.
- W171497108 cites W2129649074 @default.
- W171497108 cites W2137373998 @default.
- W171497108 cites W2148583736 @default.
- W171497108 cites W2160953471 @default.
- W171497108 cites W2162267840 @default.
- W171497108 cites W2283958142 @default.
- W171497108 hasPublicationYear "2007" @default.
- W171497108 type Work @default.
- W171497108 sameAs 171497108 @default.
- W171497108 citedByCount "0" @default.
- W171497108 crossrefType "journal-article" @default.
- W171497108 hasAuthorship W171497108A5013409247 @default.
- W171497108 hasConcept C126322002 @default.
- W171497108 hasConcept C141105273 @default.
- W171497108 hasConcept C159654299 @default.
- W171497108 hasConcept C177713679 @default.
- W171497108 hasConcept C187212893 @default.
- W171497108 hasConcept C203014093 @default.
- W171497108 hasConcept C2776042228 @default.
- W171497108 hasConcept C2776954882 @default.
- W171497108 hasConcept C2778564945 @default.
- W171497108 hasConcept C3020633164 @default.
- W171497108 hasConcept C42219234 @default.
- W171497108 hasConcept C71924100 @default.
- W171497108 hasConceptScore W171497108C126322002 @default.
- W171497108 hasConceptScore W171497108C141105273 @default.
- W171497108 hasConceptScore W171497108C159654299 @default.
- W171497108 hasConceptScore W171497108C177713679 @default.
- W171497108 hasConceptScore W171497108C187212893 @default.
- W171497108 hasConceptScore W171497108C203014093 @default.
- W171497108 hasConceptScore W171497108C2776042228 @default.
- W171497108 hasConceptScore W171497108C2776954882 @default.
- W171497108 hasConceptScore W171497108C2778564945 @default.
- W171497108 hasConceptScore W171497108C3020633164 @default.
- W171497108 hasConceptScore W171497108C42219234 @default.
- W171497108 hasConceptScore W171497108C71924100 @default.
- W171497108 hasIssue "6" @default.
- W171497108 hasLocation W1714971081 @default.
- W171497108 hasOpenAccess W171497108 @default.
- W171497108 hasPrimaryLocation W1714971081 @default.
- W171497108 hasVolume "4" @default.
- W171497108 isParatext "false" @default.
- W171497108 isRetracted "false" @default.
- W171497108 magId "171497108" @default.
- W171497108 workType "article" @default.